February 6, 2019 / 5:25 PM / 3 months ago

BRIEF-Novartis AG CEO Says No Longer Sees Net Price Growth As Meaningful Contributor

Feb 6 (Reuters) - Novartis AG:

* CEO SAYS NO LONGER SEES NET PRICE GROWTH AS MEANINGFUL CONTRIBUTOR TO LONGER TERM PLANNING

* CEO SAYS TRYING TO LIMIT OUR NET PRICE INCREASES TO MEDICAL INFLATION, OR LESS

* CEO SAYS EXPECTS OVERALL BUSINESS TO GROW MID-SINGLE-DIGITS, 4-6 PERCENT RANGE

* CEO SAYS OUTCOMES-BASED PRICING WILL BE PILLAR OF GENE, CELL THERAPIES

* CEO SAYS ‘DEEPLY DISAPPOINTED’ BY CHARACTERIZATION OF LUTATHERA CANCER MEDICINE AMID PRICE DEBATE IN THE NETHERLANDS, SAYS LAUNCHED MEDICINE AT PRICE DEEMED ‘COST EFFECTIVE’ Source text for Eikon: Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below